Mylan’s billion dollar emergency allergy treatment injector EpiPen is now being added to the list of medications in short supply by the U.S. Food and Drug Administrations, after several consumers in the U.S. with allergies found it difficult to find Mylan’s allergy device. https://news.alphastreet.com/mylans-flagship-epipen-device-is-in-shortage-in-the-u-s/
